[PHARMA] YoY Quarter Result on 31-Mar-2019 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Mar-2019 [#1]
Profit Trend
QoQ- 342.12%
YoY- 11.55%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 962,174 793,499 819,921 786,108 617,923 618,294 559,195 9.46%
PBT 37,439 31,524 30,880 30,243 28,707 27,777 26,538 5.90%
Tax -8,583 -8,696 -8,465 -10,595 -11,118 -8,519 -8,068 1.03%
NP 28,856 22,828 22,415 19,648 17,589 19,258 18,470 7.71%
-
NP to SH 27,734 23,136 22,399 19,617 17,586 18,923 18,379 7.09%
-
Tax Rate 22.93% 27.59% 27.41% 35.03% 38.73% 30.67% 30.40% -
Total Cost 933,318 770,671 797,506 766,460 600,334 599,036 540,725 9.51%
-
Net Worth 413,947 355,919 350,047 528,825 524,838 544,360 515,906 -3.60%
Dividend
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Div 10,479 10,468 15,673 15,630 12,991 10,368 10,354 0.20%
Div Payout % 37.79% 45.25% 69.98% 79.68% 73.87% 54.79% 56.34% -
Equity
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Net Worth 413,947 355,919 350,047 528,825 524,838 544,360 515,906 -3.60%
NOSH 1,309,126 261,705 261,229 260,505 259,821 259,219 258,859 30.99%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 3.00% 2.88% 2.73% 2.50% 2.85% 3.11% 3.30% -
ROE 6.70% 6.50% 6.40% 3.71% 3.35% 3.48% 3.56% -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 73.45 303.20 313.87 301.76 237.83 238.52 216.02 -16.44%
EPS 2.12 8.84 8.57 7.53 6.77 7.30 7.10 -18.23%
DPS 0.80 4.00 6.00 6.00 5.00 4.00 4.00 -23.51%
NAPS 0.316 1.36 1.34 2.03 2.02 2.10 1.993 -26.42%
Adjusted Per Share Value based on latest NOSH - 260,505
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 66.76 55.06 56.89 54.54 42.87 42.90 38.80 9.46%
EPS 1.92 1.61 1.55 1.36 1.22 1.31 1.28 6.98%
DPS 0.73 0.73 1.09 1.08 0.90 0.72 0.72 0.23%
NAPS 0.2872 0.247 0.2429 0.3669 0.3642 0.3777 0.358 -3.60%
Price Multiplier on Financial Quarter End Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 -
Price 0.755 3.26 1.26 2.27 4.28 4.89 5.76 -
P/RPS 1.03 1.08 0.40 0.75 1.80 2.05 2.67 -14.67%
P/EPS 35.66 36.88 14.69 30.14 63.23 66.99 81.13 -12.79%
EY 2.80 2.71 6.81 3.32 1.58 1.49 1.23 14.68%
DY 1.06 1.23 4.76 2.64 1.17 0.82 0.69 7.41%
P/NAPS 2.39 2.40 0.94 1.12 2.12 2.33 2.89 -3.11%
Price Multiplier on Announcement Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 20/05/22 21/05/21 19/05/20 16/05/19 16/05/18 16/05/17 13/05/16 -
Price 0.72 4.03 1.88 2.36 4.07 4.72 5.60 -
P/RPS 0.98 1.33 0.60 0.78 1.71 1.98 2.59 -14.94%
P/EPS 34.01 45.59 21.93 31.34 60.13 64.66 78.87 -13.07%
EY 2.94 2.19 4.56 3.19 1.66 1.55 1.27 15.00%
DY 1.11 0.99 3.19 2.54 1.23 0.85 0.71 7.72%
P/NAPS 2.28 2.96 1.40 1.16 2.01 2.25 2.81 -3.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment